Monoclonal gammopathy subtypes, especially IgM-MG, define distinct clinical subsets in CLL, impacting therapeutic outcomes significantly. IgM-MG is linked to poorer prognostic indicators, including ...
Researchers at the University of Eastern Finland and their international collaborators have identified key developmental and molecular differences between the two main subtypes of chronic lymphocytic ...
Pemivibart blocks spike RBD interaction with ACE2 and received FDA EUA (Pemgarda) for pre-exposure prophylaxis in moderately to severely immunocompromised patients, not for treatment or postexposure ...
Researchers at the University of Eastern Finland and their international collaborators have identified key developmental and molecular differences between the two main subtypes of chronic lymphocytic ...
Like a creature from a science fiction movie, chronic lymphocytic leukemia (CLL) can be a shape-shifter. In a small number of cases, patients with CLL will develop lymphoma, a complication known as ...
Researchers at the University of Eastern Finland and their international collaborators have identified key developmental and molecular differences between the two main subtypes of chronic lymphocytic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results